Networking Event
CalendarDate & Time
  • September 29th, 2026
LocationLocation
  • San Francisco, California
Register

Join Schrödinger to learn how our computational platform accelerates biologics discovery, optimization, and formulation.

Connect with local computational biologists, protein engineers, and translational scientists to exchange ideas on how computational modeling with real-time project data can shorten design cycles, mitigate downstream risks, and foster seamless collaboration across teams.

What we will discuss:

BioLuminate: Learn how it delivers actionable insights across traditional modalities (antibodies, peptides, biocatalysts) for early liability detection, stability, affinity, and formulation. Plus, get a sneak peek at its growing capabilities for complex non-traditional modalities like ADCs and oligonucleotides.

LiveDesign for Biologics: See how this single, shared workspace connects sequence, structure, assay data, and computed properties so your team can design, iterate, and decide faster.

Bunsen: Get a quick look at our new agentic AI tool, designed to lower the barrier to entry and accelerate design cycles by making advanced computational modeling more accessible.

Networking & Happy Hour:

Stay after the presentations to connect with local industry peers, share insights, and chat with the Schrödinger team over drinks and appetizers.

Location:

Foundry & Lux, 151 Oyster Point Blvd, South San Francisco, CA 94080

Register
icon time 3:30 PM – 4:00 PM
Welcome & Registration

Location:
Foundry and Lux, 151 Oyster Point Blvd, South San Francisco, CA 94080

icon time 4:00 PM – 5:00 PM
Biologics Workflow Presentation

Speakers:
Eliud Oloo, Global Portfolio Leader, Biologics Modeling, Schrödinger

Jason Castaneda, Executive Director, Global Portfolio Leader, Schrödinger

Sunidhi Lenka, Senior Scientist II, Applications Science, Schrödinger

icon time 5:00 PM – 7:30 PM
Networking Reception

Our Speakers

Eliud Oloo

Senior Director, Global Portfolio Leader, Schrödinger

In his current role leading Schrödinger’s biologics modeling portfolio, Eliud enables R&D teams to translate advanced computational modeling insights into real-world drug discovery success. From basic and applied scientific research to product strategy, his background brings a unique cross-disciplinary perspective on solving biology’s toughest problems through computation. Previously, he headed structure-based modeling of vaccines at Sanofi, where he pioneered the application of machine learning to antigen design. He also served as Product Manager for BioLuminate, Schrödinger’s globally adopted biologics platform. Eliud is a co-inventor and co-author on multiple patents and publications in biologics design. He holds a PhD in Biomolecular Simulation from the University of Calgary, Canada.

Sunidhi Lenka

Senior Scientist II, Applications Science, Schrödinger

Sunidhi Lenka is a Senior Scientist II in the Application Science team at Schrödinger. Joined in 2023, her primary focus is supporting customers in deploying the Schrödinger drug discovery suite within their workflows, alongside driving her own research and building strategic collaborations to advance work in both biologics and small molecules. Sunidhi earned her Ph.D. in Computational Chemistry from the University of Florida under Prof. Adrian Roitberg, specializing in QM/MM and enhanced sampling MD techniques for medicinal chemistry and enzyme engineering. She subsequently completed a postdoctoral fellowship at Genentech in Dr. Izadi’s lab, developing in silico tools to address high concentration viscosity challenges and chemical degradation risks (such as tryptophan oxidation and CQAs) in biologics.

Cindy Gerson

Senior Lead Product Manager, Enterprise Informatics, Schrödinger

Cindy Gerson, senior lead product manager, enterprise informatics, joined Schrödinger in 2022. In her role, she leads the LiveDesign for Biologics development efforts – using her extensive knowledge and years of first-hand experience at the lab bench to design software tools that expedite and improve biologics discovery workflows. Prior to joining Schrödinger, Cindy worked at Regeneron Pharmaceuticals in the field of monoclonal antibody-based therapeutics discovery, where she developed, optimized, and executed platforms for the isolation of target-specific antibodies. She completed her BS in Biomedical Engineering at Columbia University and her MS in Bioengineering at Georgia Tech.